Gene Mutation Identifies Colorectal Cancer Patients Who Live Longer with Aspirin Therapy

Aspirin therapy can extend the life of colorectal cancer patients whose tumors carry a mutation in a key gene, but has no effect on patients who lack the mutation, Dana-Farber Cancer Institute scientists report in the Oct. 25 issue of the New England Journal of Medicine.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews